KMTS
NASDAQKestra Medical Technologies Ltd.
Price$24.28+1.05 (+4.52%)
01:30 PM07:45 PM
News · 26 weeks38+100%
2026-01-182026-07-12
Mix2190d
- Insider14(67%)
- Other3(14%)
- Earnings2(10%)
- SEC Filings2(10%)
Latest news
25 items- INSIDERChief Business Officer Moran Timothy P. was granted 39,113 shares, increasing direct ownership by 92% to 81,601 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDERChief Commercial Officer Ford Alfred J Jr was granted 58,832 shares, increasing direct ownership by 79% to 133,471 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDERChief Financial Officer Mahboob Vaseem was granted 44,118 shares, increasing direct ownership by 65% to 112,079 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDEROfficer Umberger Traci S was granted 58,832 shares, increasing direct ownership by 36% to 221,634 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDEROfficer Webster Brian Daniel was granted 176,470 shares and sold $336,609 worth of shares (15,000 units at $22.44) as part of a pre-agreed trading plan, increasing direct ownership by 41% to 556,937 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- SECSEC Form 10-K filed by Kestra Medical Technologies Ltd.10-K - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Filer)
- SECKestra Medical Technologies Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Filer)
- PRKestra Medical Technologies Secures Up to $200 Million of Non-Dilutive FinancingKIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a leading wearable medical device and digital healthcare company, today announced that it has entered into a five-year term loan facility with funds managed by Pharmakon Advisors, LP. The non-dilutive financing consists of: $75 million tranche funded at closing, a portion of which was used to retire Kestra’s existing $45 million term loan and pay fees and expenses.$25 million tranche available at Kestra’s option through July 2027.$50 million tranche available at Kestra’s option through June 2028, subject to generating $150 million of trailing 12-months revenue.$50 million uncommitted tranc
- PRKestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial ResultsKIRKLAND, Wash., July 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the fourth quarter and fiscal year ended April 30, 2026. Financial Highlights Fiscal 4Q26 revenue of $28.6 million, an increase of 66% compared to the prior year period.FY26 revenue of $95.1 million, an increase of 59% compared to FY25.Fiscal 4Q26 gross margin of 54.8% compared to 44.3% in the prior year period.FY26 gross margin of 51.4% compared to 40.5% in FY25.FY27 revenue guidance of $137 million, an increase of 44% compared to fiscal year 2026. "Kestra concluded fiscal year 2026 wit
- INSIDERChief Business Officer Moran Timothy P. was granted 227 shares, increasing direct ownership by 0.54% to 42,488 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDEROfficer Umberger Traci S was granted 942 shares, increasing direct ownership by 0.58% to 162,802 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- PRKestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14KIRKLAND, Wash., June 30, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report fourth quarter fiscal 2026 financial results after the market closes on Tuesday, July 14. Management will host a conference call at 4:30 p.m. Eastern Time to discuss financial results. A live and archived webcast of the conference call will be available in the "Events" section of the investor relations website. About KestraKestra Medical Technologies, Ltd. is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitor
- INSIDEROfficer Webster Brian Daniel sold $312,142 worth of shares (15,000 units at $20.81) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 395,467 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDERChief Business Officer Moran Timothy P. was granted 22,704 shares, increasing direct ownership by 116% to 42,261 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDERChief Commercial Officer Ford Alfred J Jr was granted 25,227 shares, increasing direct ownership by 51% to 74,639 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDERChief Financial Officer Mahboob Vaseem was granted 25,227 shares, increasing direct ownership by 59% to 67,961 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDEROfficer Umberger Traci S was granted 25,227 shares, increasing direct ownership by 18% to 161,860 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDEROfficer Webster Brian Daniel was granted 75,681 shares, increasing direct ownership by 23% to 410,467 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- INSIDEROfficer Webster Brian Daniel sold $314,329 worth of shares (15,000 units at $20.96) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 334,786 units (SEC Form 4)4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- PRKestra Medical Technologies to Present at the BofA Securities 2026 Healthcare ConferenceKIRKLAND, Wash., April 29, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a leading wearable medical device and digital healthcare company, is scheduled to present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13 at 2:20 p.m. Pacific Time. Interested parties may access the live webcast and a replay of the presentation by visiting the Kestra investor relations website. About Kestra Medical TechnologiesKestra Medical Technologies is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, i
- PRKestra Showcases Accelerated Innovation at HRS 2026KIRKLAND, Wash., April 22, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a leading wearable medical device and digital healthcare company, today announced it will exhibit at Heart Rhythm 2026, the annual meeting of the Heart Rhythm Society (HRS) taking place April 23–26 in Chicago. The company will showcase its Cardiac Recovery System® platform—a modern, integrated approach to managing sudden cardiac arrest (SCA) risk that unites proven therapy, actionable clinical insights, and ongoing patient support to enhance protection and optimize care. Kestra, one of the fastest-growing companies in medical technology, continues to build momentum as clinicians increasing
- INSIDERSEC Form 4 filed by Webster Brian Daniel4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer)
- PRKestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award WinnerKIRKLAND, Wash., April 09, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), a leading wearable medical device and digital healthcare company, today announced it has been named a 2026 USA TODAY Top Workplaces award winner. "Being named a USA TODAY Top Workplace highlights a team dedicated to a meaningful purpose and mission with a commitment to making a real difference for patients and clinicians," said Brian Webster, President and CEO of Kestra Medical Technologies. "The opportunity to collaborate with people who share that responsibility creates strong alignment, defines our culture, and empowers our teams to work together to develop innovative, life-saving techn
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Kestra Medical Technologies Ltd.SCHEDULE 13G/A - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Subject)
- SECSEC Form S-3ASR filed by Kestra Medical Technologies Ltd.S-3ASR - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Filer)
KMTS FAQ
6 questionsWhere does KMTS stock trade?
Kestra Medical Technologies Ltd. (KMTS) is listed on NASDAQ.What sector and industry is KMTS in?
Kestra Medical Technologies Ltd. operates in the Health Care sector, Medical/Dental Instruments industry.When did Kestra Medical Technologies Ltd. go public?
Kestra Medical Technologies Ltd. (KMTS) completed its IPO in 2025.What are analysts saying about KMTS?
Kestra Medical Technologies Ltd. has had 7 recent analyst actions on file. The most recent action was from BTIG Research: Buy with a $3200.00 price target on 2025-11-18. Recent price targets range from $2400.00 to $3200.00.What companies are similar to KMTS?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare KMTS side-by-side with any of them on Quantisnow.How can I track KMTS on Quantisnow?
Quantisnow aggregates Kestra Medical Technologies Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow KMTS to receive live email and push alerts on every new disclosure.